<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> markers (TM) play an important role in the management of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This study evaluates the predictive and prognostic value of preoperative serum carbohydrate antigen 242 (CA242) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: Preoperative serum CA242 level was detected by C12 protein-chip diagnostic system in 185 CRC patients, and the predictive value of CA242 in stage, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion depth was assessed </plain></SENT>
<SENT sid="3" pm="."><plain>The prognostic value of CA242 for 5-year overall survival (OS) was analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: CA242 positive rate elevated with stage advancing, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion depth, the differences between stage III+IV and stage I+II, between positive lymph node and negative lymph node, between T3+T4 and T1+T2, reached statistical significance (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Receiver operating characteristic analysis demonstrated that the area under the curve of CA242 in stage, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion depth were 0.677, 0.631 and 0.744, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with higher CA242 had worse 5-year OS compared to those with <z:mpath ids='MPATH_458'>normal</z:mpath> CA242 (p=0.0002) </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate analysis showed stage (p=0.000) and preoperative serum CA242 (p=0.026) as independent prognostic factors for 5-year OS of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The preoperative serum CA242 can predict stage, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion depth, and can be used as an independent prognostic factor for OS of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>